Advanced search
Publication Cover
Leukemia & Lymphoma Volume 54, 2013 - Issue 11
Submit an article Journal homepage
152
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Prognostic value of high thymidine kinase activity in patients with previously untreated diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone

Kazuhito SuzukiDepartment of Medical Hematology/Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan;Department of Clinical Oncology/Hematology, The Jikei University School of Medicine, Tokyo, Japan
,
Yasuhito TeruiDepartment of Medical Hematology/Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
,
Masahiro YokoyamaDepartment of Medical Hematology/Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
,
Kyoko UedaDepartment of Medical Hematology/Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
,
Noriko NishimuraDepartment of Medical Hematology/Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
,
Yuko MishimaDepartment of Medical Hematology/Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
,
Sakura SakajiriDepartment of Medical Hematology/Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
,
Naoko TsuyamaDepartment of Pathology
,
Kengo TakeuchiPathology Project for Molecular Targets, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan
&
Kiyohiko HatakeDepartment of Medical Hematology/Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, JapanCorrespondence[email protected]
 show all
Pages 2412-2417 | Received 03 Nov 2012, Accepted 21 Feb 2013, Published online: 14 Mar 2013

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Clemens-Martin Wendtner. (2013) There is life in the old dog yet: thymidine kinase as predictive marker in diffuse large B-cell lymphoma. Leukemia & Lymphoma 54:11, pages 2343-2344.
Read now

Articles from other publishers (5)

Bushra Zaidi, Abhijit Mukhopadhyay, José A. Ramos‐Vara, Deepika Dhawan, Audrey Ruple & Michael O. Childress. (2023) Serum thymidine kinase 1 activity as a prognostic biomarker in dogs with chemotherapy‐treated diffuse large B‐cell lymphoma. Veterinary and Comparative Oncology 21:2, pages 200-207.
Crossref
Joel C. Wight, Geoffrey Chong, Andrew P. Grigg & Eliza A. Hawkes. (2018) Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI. Blood Reviews 32:5, pages 400-415.
Crossref
Bin Liu, Bo Li, Pingting Zhou, Wenqin Yue, Tao Wang, Jianmin Wang, Xiaoxia Hu, Weiping Zhang, Jie Chen, Li Chen, Lei Gao, Miaoxia He & Jianmin Yang. (2018) Prognostic value of pretreatment plasma D-dimer levels in patients with diffuse large B cell lymphoma (DLBCL). Clinica Chimica Acta 482, pages 191-198.
Crossref
Yusuke Kanemasa, Tatsu Shimoyama, Yuki Sasaki, Miho Tamura, Takeshi Sawada, Yasushi Omuro, Tsunekazu Hishima & Yoshiharu Maeda. (2017) Beta-2 microglobulin as a significant prognostic factor and a new risk model for patients with diffuse large B-cell lymphoma. Hematological Oncology 35:4, pages 440-446.
Crossref
Kazuho Miyashita, Naoto Tomita, Masataka Taguri, Taisei Suzuki, Yasufumi Ishiyama, Yoshimi Ishii, Yuki Nakajima, Ayumi Numata, Yukako Hattori, Wataru Yamamoto, Takuya Miyazaki, Takayoshi Tachibana, Hirotaka Takasaki, Kenji Matsumoto, Chizuko Hashimoto, Sachiya Takemura, Etsuko Yamazaki, Katsumichi Fujimaki, Rika Sakai, Shigeki Motomura & Yoshiaki Ishigatsubo. (2015) Beta-2 microglobulin is a strong prognostic factor in patients with DLBCL receiving R-CHOP therapy. Leukemia Research 39:11, pages 1187-1191.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.